Skinvisible Inc. | SFWJ DBA MedCana

Stock Day Media

Skinvisible, Inc. (OTCQB:SKVI) is excited to share a promising update on the ongoing clinical trials conducted by its licensee, Quoin Pharmaceuticals, Inc. (NASDAQ:QNRX). The trials focus on the innovative formulation “QRX003,” powered by Skinvisible’s Invisicare® proprietary drug delivery technology, to address the challenges of Netherton Syndrome (“NS”).
SFWJ DBA MedCana announces that Eko2o S.A.S, a Majority Controlled subsidiary of MedCana/SWJ in Colombia and a leading provider of greenhouse infrastructure and agricultural technology, proudly announces a significant partnership with Danziger Colombia. This strategic agreement, expected to generate between $2.5 million and $3 million in revenue over the next three years, marks a pivotal moment for both organizations in their commitment to innovative agricultural practices.
Eko2o will be providing greenhouse infrastructure services, irrigation products and technology as well as other technologies related to Danziger’s flower operations in Colombia.
For more information, visit StockDayMedia.com